Advertisement
Original article| Volume 124, ISSUE 2, P199-209, August 1994

Download started.

Ok

β-Hydroxybutyrate decreases adenosine triphosphate degradation products in human subjects

  • Boris Lestan
    Footnotes
    Affiliations
    Ann Arbor, Michigan USA

    From the Departments of Internal Medicine and Biological Chemistry, Clinical Research Center, University Hospital USA
    Search for articles by this author
  • Katherine Walden
    Affiliations
    Ann Arbor, Michigan USA

    From the Departments of Internal Medicine and Biological Chemistry, Clinical Research Center, University Hospital USA
    Search for articles by this author
  • Stephen Schmaltz
    Affiliations
    Ann Arbor, Michigan USA

    From the Departments of Internal Medicine and Biological Chemistry, Clinical Research Center, University Hospital USA
    Search for articles by this author
  • Jozef Spychala
    Affiliations
    Ann Arbor, Michigan USA

    From the Departments of Internal Medicine and Biological Chemistry, Clinical Research Center, University Hospital USA
    Search for articles by this author
  • Irving H. Fox
    Correspondence
    Reprint requests: I. H. Fox, Biogen, Inc., 14 Cambridge Center, Cambridge, MA 02142.
    Affiliations
    Ann Arbor, Michigan USA

    From the Departments of Internal Medicine and Biological Chemistry, Clinical Research Center, University Hospital USA
    Search for articles by this author
  • Author Footnotes
    1 Dr. Lestan was a postdoctoral fellow of the Rackham Arthritis Research Unit supported by the Research Council of the Republic of Slovenia, Yugoslavia, Grant No. C30652/352-89.
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Many disease states decrease intracellular adenosine triphosphate (ATP) levels and elevate body fluid purine levels. The use of specific metabolic substrates may reverse this process. This study was designed to test the hypothesis that β-hydroxybutyrate, a substrate for ATP synthesis, decreases body fluid purine levels during interventions that induce ATP degradation. Decreases in these purine levels are metabolic markers for diminished ATP degradation. Two human models for stimulating ATP degradation were used to test the hypothesis. Rapid fructose infusion causes acute degradation of hepatic ATP, and ischemie exercise stimulates ATP consumption in skeletal muscle. The activity of β-hydroxybutyrate was used in combination with phosphate, another important substrate for ATP synthesis. The studies were performed during a low-phosphate state in 10 normal subjects and during a high-phosphate state in 7 normal subjects. Metabolic variables, such as serum or urinary phosphate level, blood β-hydroxybutyrate level, blood acetoacetate level, plasma or urinary purine level, blood lactate level, and blood ammonia level, were monitored during the study. After ischemic exercise of the forearm muscle, β-hydroxybutyrate decreased the level of plasma total purines, blood lactate, and blood ammonia during the low-phosphate state but not during the high-phosphate state. During fructose-induced hepatic ATP breakdown, β-hydroxybutyrate decreased late phase plasma purine increases under low-phosphate conditions only and decreased urinary total and radiolabeled purine elevations under both phosphate conditions. These data indicate that the infusion of β-hydroxybutyrate may alter the balance from ATP degradation toward ATP resynthesis in muscle and liver by providing an immediate source of fuel and reducing equivalents under under specific metabolic conditions. This activity in combination with other metabolic interventions may have therapeutic value by restoring ATP pools in ATP-depleted tissues.

      Abbreviations:

      AMP (adenosine monophosphate), ATP (adenosine triphosphate), CoA (coenzyme A), CRC (University of Michigan Clinical Research Center), NADH (reduced nicotinamide adenine dinucleotide), Pi (inorganic phosphate)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fox IH
        Adenosine triphosphate in specific disease.
        J Lab Clin Med. 1985; 1106: 101-110
        • Palella TD
        • Fox IH
        Hyperuricemia and gout.
        in: Scriver CR Beaudet AL Sly WS Valle D The metabolic basis of inherited disease. 6th ed. McGraw-Hill, New York1989: 965-1006
        • Mateos F
        • Gomez P
        • Puig J
        • Jimenez M
        • Ramos T
        • Matilla J
        Enhanced adenine nucleotide degradation in chronic obstructive pulmonary disease: The effect of oxygen therapy.
        Pediatr Res. 1988; 24: 125
        • Johnson MA
        • Tekkanat K
        • Schmaltz SP
        • Fox IH
        Adenosine triphosphate turnover in human: decreased degradation during relative hyperphosphatemia.
        J Clin Invest. 1989; 84: 990-995
        • Siess EA
        Stimulation by 3-hydroxybutyrate of pyruvate carboxylation in mitochondria from rat liver.
        Eur J Biochem. 1985; 152: 131-136
        • Siess EA
        • Bainik E
        • Neugebauer S
        Control of pyruvate carboxylase activity by the pyridine-nucleotide redox state in mitochondria from rat liver.
        Eur J Biochem. 1988; 173: 369-374
        • Fox IH
        • Kelley WN
        Studies on the mechanism of fructose induced hyperuricemia in man.
        Metabolism. 1972; 21: 713-721
        • Bertorini TE
        • Shively V
        • Taylor B
        • Palmieri GMA
        • Fox IH
        ATP degradation products after ischemie exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
        Neurology. 1985; 35: 1355-1357
        • Hassinen IE
        Mitochondrial respiratory control in the myocardium.
        Biochem Biophys Acta. 1986; 853: 1345-1351
        • Tanaka A
        • Chance B
        • Quistorff B
        A possible role of inorganic phosphate as a regulator of oxidative phosphorylation in combined urea synthesis and gluconeogenesis in perfused rat liver.
        J Biol Chem. 1989; 264: 10034-10040
        • Weisner R
        • Kreutzer U
        • Rosen P
        • Grieshaber MK
        Subcellular distribution of malate-aspartate cycle intermediates during norinoxia and anoxia in the heart.
        Biochem Biophys Acta. 1988; 936: 115-123
        • Martinez P
        • Carrascosa JM
        • Nurez de Castro I
        Ketose induced respiratory inhibition in isolated hepatocytes.
        Rev Esp Fisiol. 1987; 43: 163-172
        • Denton RM
        • Randle PJ
        • Bridges BJ
        • et al.
        Regulation of mammalian pyruvate dehydrogenase.
        Mol Cel Biochem. 1975; 9: 27-53
        • Cuendet GS
        • Loten EG
        • Renold AE
        Evidence that the glucosefatty acid cycle is operative in isolated skeletal (soleus) muscle.
        Diabetologia. 1975; 11: 336
        • Blackard WG
        • Clore JN
        Model to examine pathways of carbon flux from lactate to glucose at the first point in gluconeogenesis.
        J Biol Chem. 1988; 263: 16725-16730
        • Miles JM
        • Haymond MW
        • Gerich JE
        Suppression of glucose production and stimulation of insulin secretion by physiological concentrations of ketone bodies in man.
        J Clin Endocrinol Metab. 1981; 52: 34-37
        • Miles JM
        • Nissen SL
        • Rizza RA
        • Gerich JE
        • Haymond MW
        Failure of infused β-hydroxybutyrate to decrease proteolysis in man.
        Diabetes. 1983; 32: 197-205
        • Nair KS
        • Welle SL
        • Halliday D
        • Campbell RG
        Effect of β-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans.
        J Clin Invest. 1988; 82: 198-205
        • Edwards NL
        • Recker DM
        • Fox IH
        Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency.
        J Clin Invest. 1979; 73: 922-930
        • Edwards NL
        • Recker D
        • Airozo D
        • Fox IH
        Enhanced purine salvage during allopurinol therapy: an important pharmacologic property in humans.
        J Lab Clin Med. 1981; 98: 673-683
        • Munsat TL
        A standardized forearm ischemic exercisc test.
        Neurology. 1970; 20: 1171-1178
        • Liddle L
        • Seegmiller JE
        • Laster L
        The enzymatic spectrophotometric method for determination of uric acid.
        J Lab Clin Med. 1959; 54: 903-913
        • Tekkanat K
        • Fox IH
        Isocratic separation of ATP and its degradation products from biological fluids by automated liquid chromatography.
        Clin Chem. 1988; 34: 925-932
      1. 2nd ed. Technicon Auto Analyzer R method file (method N116). Technicon Instrument Corp, Tarrytown, New York1969
        • Mellanby J
        • Williamson DH
        Acetoacetate.
        in: Bergmeyer H Methods of enzymatic analysis. 2nd ed. Academic Press, New York1974: 1840-1843
        • Gutman I
        • Wahlefeld AW
        Lactate.
        in: Bergmeyer H Methods of enzymatic analysis. 2nd ed. Academic Press, New York1974: 1464-1468
        • Goldfinger S
        • Klinenberg JR
        • Seegmiller JE
        Renal retention of uric acid induced by infusion of β-hydroxybutyrate and acetoacetate.
        N Engl J Med. 1965; 272: 351-355
        • Mateos FA
        • Puig JD
        • Jiminez ML
        • Fox IH
        Hereditary xanthinuria: evidence for enhanced hypoxanthine salvage.
        J Clin Invest. 1987; 79: 847-852
        • Sabina RL
        • Swain JL
        • Holmes EW
        Myoadenylate deaminase deficiency.
        in: Scriver CR Beaudet AL Sly WS Valle D The metabolic basis of inherited disease. 6th ed. McGraw-Hill, Inc, 1989: 1077-1084
        • Haller RG
        • Lewis SF
        Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency.
        N Engl J Med. 1991; 324: 364-369
        • Layzer RB
        How muscles use fuel.
        N Engl J Med. 1991; 324: 411-412